ArticleInternal medicine (Tokyo, Japan)2022

Safe Concurrent Use of Anti-tuberculosis Drugs and Pembrolizumab in a Patient with Non-small-cell Lung Cancer Who Was Infected with Mycobacterium tuberculosis.

Kenji Nakahama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.